Annual Accounts Payable
$993.10 K
+$502.40 K+102.38%
December 31, 2023
Summary
- As of February 7, 2025, ZIVO annual accounts payable is $993.10 thousand, with the most recent change of +$502.40 thousand (+102.38%) on December 31, 2023.
- During the last 3 years, ZIVO annual accounts payable has fallen by -$566.50 thousand (-36.32%).
- ZIVO annual accounts payable is now -36.32% below its all-time high of $1.56 million, reached on December 31, 2020.
Performance
ZIVO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$923.90 K
-$249.00 K-21.23%
September 30, 2024
Summary
- As of February 7, 2025, ZIVO quarterly accounts payable is $923.90 thousand, with the most recent change of -$249.00 thousand (-21.23%) on September 30, 2024.
- Over the past year, ZIVO quarterly accounts payable has dropped by -$241.90 thousand (-20.75%).
- ZIVO quarterly accounts payable is now -51.40% below its all-time high of $1.90 million, reached on September 30, 2020.
Performance
ZIVO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ZIVO Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +102.4% | -20.8% |
3 y3 years | -36.3% | +88.3% |
5 y5 years | +135.1% | +88.3% |
ZIVO Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +102.4% | -27.4% | +126.6% |
5 y | 5-year | -36.3% | +102.4% | -51.4% | +126.6% |
alltime | all time | -36.3% | -100.0% | -51.4% | -100.0% |
ZIVO Bioscience Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $923.90 K(-21.2%) |
Jun 2024 | - | $1.17 M(+27.9%) |
Mar 2024 | - | $917.00 K(-21.3%) |
Dec 2023 | $993.10 K(+102.4%) | $1.17 M(+81.1%) |
Sep 2023 | - | $643.80 K(-49.4%) |
Jun 2023 | - | $1.27 M(+90.0%) |
Mar 2023 | - | $670.30 K(+36.6%) |
Dec 2022 | $490.70 K(-25.0%) | $490.70 K(-19.2%) |
Sep 2022 | - | $607.00 K(+48.8%) |
Jun 2022 | - | $407.80 K(-21.6%) |
Mar 2022 | - | $520.40 K(-20.5%) |
Dec 2021 | $654.30 K(-58.0%) | $654.30 K(-10.2%) |
Sep 2021 | - | $728.80 K(-20.6%) |
Jun 2021 | - | $918.30 K(-47.1%) |
Mar 2021 | - | $1.74 M(+11.3%) |
Dec 2020 | $1.56 M(+13.6%) | $1.56 M(-18.0%) |
Sep 2020 | - | $1.90 M(+27.9%) |
Jun 2020 | - | $1.49 M(-18.5%) |
Mar 2020 | - | $1.82 M(+32.9%) |
Dec 2019 | $1.37 M(+224.9%) | $1.37 M(+42.6%) |
Sep 2019 | - | $962.20 K(-17.5%) |
Jun 2019 | - | $1.17 M(+45.2%) |
Mar 2019 | - | $802.80 K(-6.1%) |
Dec 2018 | $422.40 K(-22.0%) | $854.90 K(+117.5%) |
Sep 2018 | - | $393.10 K(-12.7%) |
Jun 2018 | - | $450.40 K(-60.2%) |
Mar 2018 | - | $1.13 M(+11.2%) |
Dec 2017 | $541.70 K(-18.7%) | $1.02 M(+60.2%) |
Sep 2017 | - | $635.00 K(-16.5%) |
Jun 2017 | - | $760.10 K(-1.2%) |
Mar 2017 | - | $769.10 K(+15.4%) |
Dec 2016 | $666.40 K(-40.2%) | $666.40 K(-19.1%) |
Sep 2016 | - | $823.70 K(-25.9%) |
Jun 2016 | - | $1.11 M(-11.1%) |
Mar 2016 | - | $1.25 M(+12.2%) |
Dec 2015 | $1.11 M(-9.1%) | $1.11 M(-8.6%) |
Sep 2015 | - | $1.22 M(+2.7%) |
Jun 2015 | - | $1.19 M(-14.1%) |
Mar 2015 | - | $1.38 M(+12.8%) |
Dec 2014 | $1.23 M(+153.6%) | $1.23 M(+153.7%) |
Sep 2014 | - | $483.00 K(-29.2%) |
Jun 2014 | - | $682.40 K(+13.7%) |
Mar 2014 | - | $600.40 K(+24.3%) |
Dec 2013 | $483.20 K(-48.5%) | $483.20 K(-48.5%) |
Sep 2013 | - | $938.80 K(+17.0%) |
Jun 2013 | - | $802.50 K(-12.3%) |
Mar 2013 | - | $915.00 K(-2.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | $938.60 K(+42.1%) | $938.60 K(+7.3%) |
Sep 2012 | - | $874.70 K(+21.0%) |
Jun 2012 | - | $723.00 K(+10.3%) |
Mar 2012 | - | $655.50 K(-0.8%) |
Dec 2011 | $660.60 K(+45.0%) | $660.60 K(+8.4%) |
Sep 2011 | - | $609.40 K(-1.6%) |
Jun 2011 | - | $619.20 K(+20.2%) |
Mar 2011 | - | $515.00 K(+13.0%) |
Dec 2010 | $455.60 K(-15.9%) | $455.60 K(-5.7%) |
Sep 2010 | - | $482.90 K(-1.8%) |
Jun 2010 | - | $491.90 K(-3.0%) |
Mar 2010 | - | $507.30 K(-6.4%) |
Dec 2009 | $541.90 K(+6.4%) | $541.90 K(+13.0%) |
Sep 2009 | - | $479.70 K(-9.1%) |
Jun 2009 | - | $528.00 K(+2.9%) |
Mar 2009 | - | $513.10 K(+0.7%) |
Dec 2008 | $509.30 K(-4.5%) | $509.30 K(-11.5%) |
Sep 2008 | - | $575.70 K(+24.5%) |
Jun 2008 | - | $462.50 K(+3.4%) |
Mar 2008 | - | $447.50 K(-16.1%) |
Dec 2007 | $533.30 K(+6.6%) | $533.30 K(+13.9%) |
Sep 2007 | - | $468.20 K(+10.2%) |
Jun 2007 | - | $424.80 K(+7.7%) |
Mar 2007 | - | $394.50 K(-21.2%) |
Dec 2006 | $500.50 K(+212.6%) | $500.50 K(+105.8%) |
Sep 2006 | - | $243.20 K(+16.3%) |
Jun 2006 | - | $209.20 K(+144.7%) |
Mar 2006 | - | $85.50 K(-46.6%) |
Dec 2005 | $160.10 K(-60.7%) | $160.10 K(+171.8%) |
Sep 2005 | - | $58.90 K(+69.7%) |
Jun 2005 | - | $34.70 K(-88.7%) |
Mar 2005 | - | $307.60 K(-24.4%) |
Dec 2004 | $406.90 K(+1401.5%) | $406.90 K(+90.3%) |
Sep 2004 | - | $213.80 K(+142.1%) |
Jun 2004 | - | $88.30 K(+99.8%) |
Mar 2004 | - | $44.20 K(+63.1%) |
Dec 2003 | $27.10 K(>+9900.0%) | $27.10 K(>+9900.0%) |
Sep 2002 | - | $0.00(0.0%) |
Jun 2002 | - | $0.00(0.0%) |
Mar 2002 | - | $0.00(0.0%) |
Dec 2001 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2001 | - | $0.00(0.0%) |
Jun 2001 | - | $0.00(0.0%) |
Mar 2001 | - | $0.00(-100.0%) |
Dec 2000 | $1600.00 | $1600.00(>+9900.0%) |
Sep 2000 | - | $0.00(0.0%) |
Jun 2000 | - | $0.00 |
FAQ
- What is ZIVO Bioscience annual accounts payable?
- What is the all time high annual accounts payable for ZIVO Bioscience?
- What is ZIVO Bioscience annual accounts payable year-on-year change?
- What is ZIVO Bioscience quarterly accounts payable?
- What is the all time high quarterly accounts payable for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly accounts payable year-on-year change?
What is ZIVO Bioscience annual accounts payable?
The current annual accounts payable of ZIVO is $993.10 K
What is the all time high annual accounts payable for ZIVO Bioscience?
ZIVO Bioscience all-time high annual accounts payable is $1.56 M
What is ZIVO Bioscience annual accounts payable year-on-year change?
Over the past year, ZIVO annual accounts payable has changed by +$502.40 K (+102.38%)
What is ZIVO Bioscience quarterly accounts payable?
The current quarterly accounts payable of ZIVO is $923.90 K
What is the all time high quarterly accounts payable for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly accounts payable is $1.90 M
What is ZIVO Bioscience quarterly accounts payable year-on-year change?
Over the past year, ZIVO quarterly accounts payable has changed by -$241.90 K (-20.75%)